康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元

财华社2021-03-31

原标题：康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元　　【财华社讯】康方生物-B(09926-HK)公布2020年度业绩，年内亏损扩大至13.21亿元(人民币。下同)，同比亏损扩大了281.2%；其中涉及非现金一次性可转换可赎回优先股的公允价变动3.15亿元。　　期内收入为0.71亿元，来自收到与对外授权产品AK107有关的里程碑付款。其他收入及...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2123222555?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89","is_english":false,"pubTime":"2021-03-31 19:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2123222555","market":"hk","top_or_hot":-1,"title":"康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元","media":"财华社","content":"<div>\n<p>原标题：康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元\r\n            \n　　【财华社讯】康方生物-B(09926-HK)公布2020年度业绩，年内亏损扩大至13.21亿元(人民币。下同)，同比亏损扩大了281.2%；其中涉及非现金一次性可转换可赎回优先股的公允价变动3.15亿元。\n　　期内收入为0.71亿元，来自收到与对外授权产品AK107有关的里程碑付款。其他收入及...</p>\n\n<a href=\"http://hk.eastmoney.com/a/202103311867376930.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-31 19:13 北京时间&nbsp;&nbsp;&nbsp;<a href=http://hk.eastmoney.com/a/202103311867376930.html><strong>财华社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>原标题：康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元\r\n            \n　　【财华社讯】康方生物-B(09926-HK)公布2020年度业绩，年内亏损扩大至13.21亿元(人民币。下同)，同比亏损扩大了281.2%；其中涉及非现金一次性可转换可赎回优先股的公允价变动3.15亿元。\n　　期内收入为0.71亿元，来自收到与对外授权产品AK107有关的里程碑付款。其他收入及...</p>\n\n<a href=\"http://hk.eastmoney.com/a/202103311867376930.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09926","symbol_name":"康方生物","start_time":0,"source_url":"http://hk.eastmoney.com/a/202103311867376930.html","article_id":"2123222555","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/0dadac519bb6258dbafe32faf8a03d89"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2123222555","pubTimestamp":1617189180,"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"【财华社讯】康方生物-B(09926-HK)公布2020年度业绩，年内亏损扩大至13.21亿元(人民币。下同)，同比亏损扩大了281.2%；其中涉及非现金一次性可转换可赎回优先股的公允价变动3.15亿...","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"09926":"康方生物"},"translate_title":"The loss of Kangfang Bio-B (09926-HK) expanded by 2.8 times to 1.321 billion yuan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"90010":1,"09926":1},"content_text":"原标题：康方生物-B(09926-HK)亏损扩大2.8倍至13.21亿元\r\n            \n　　【财华社讯】康方生物-B(09926-HK)公布2020年度业绩，年内亏损扩大至13.21亿元(人民币。下同)，同比亏损扩大了281.2%；其中涉及非现金一次性可转换可赎回优先股的公允价变动3.15亿元。\n　　期内收入为0.71亿元，来自收到与对外授权产品AK107有关的里程碑付款。其他收入及收益146%至1.235亿元，由于公司于联交所首次公开发售所得款项赚取的利息及当地政府对研发活动的补助增加。研发开支增加149.2%至7.686亿元，主要是由于临床试验发展及研发人员的数目及雇员薪金及相关福利成本(包括权益结算的股份奖励开支)增加导致的员工成本增加所致。\n　　行政开支增加356.7%至2.53亿元，主要是由于与首次公开发售有关的上市开支增加、雇员薪金及福利(包括权益结算的股份奖励开支)增加以及非研发人员的数目增加所致。\n　　港交所原文（文章来源：财华社）\n\r\n                (责任编辑：DF544)","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2123222555"}